# La Jolla Pharmaceutical Company (LJPC)

Source: https://www.quantisnow.com/company/LJPC
Generated: 2026-11-10T01:25:08.022Z

- Ticker: LJPC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 1994
- Website: lajollapharmaceutical.com

## About

La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age and older. It offers GIAPREZA and XERAVA to hospitals and other healthcare organizations in the United States. Its product candidates that are in early stage clinical or preclinical development include TP-6076, an IV formulation of a fully synthetic fluorocycline derivative for the treatment of certain multidrug-resistant gram-negative bacteria; TP-271, an IV and oral formulation of a fully synthetic fluorocycline for the treatment of respiratory disease caused by bacterial biothreat and antibiotic-resistant public health pathogens, as well as bacterial pathogens associated with community-acquired bacterial pneumonia; and TP-2846, an IV formulation of a tetracycline for the treatment of acute myeloid leukemia. The company was incorporated in 1989 and is headquartered in San Diego, California.

## Latest LJPC news and filings

- 2022-09-01 12:38 UTC [SEC Form 15-12G filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-la-jolla-pharmaceutical-company-3363606)
- 2022-08-29 16:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by La Jolla Pharmaceutical Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-la-jolla-pharmaceutical-company-3347161)
- 2022-08-29 16:07 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-la-jolla-pharmaceutical-company-3346919)
- 2022-08-25 00:27 UTC [SEC Form 4] [SEC Form 4 filed by Rosen Robert](https://www.quantisnow.com/insight/sec-form-4-filed-by-rosen-robert-3330142)
- 2022-08-25 00:22 UTC [SEC Form 4] [SEC Form 4: Ramsay David A returned $623,000 worth of shares to the company (100,000 units at $6.23), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-ramsay-david-a-returned-623000-worth-of-3330128)
- 2022-08-25 00:21 UTC [SEC Form 4] [SEC Form 4 filed by Tang Kevin C](https://www.quantisnow.com/insight/sec-form-4-filed-by-tang-kevin-c-3330125)
- 2022-08-25 00:20 UTC [SEC Form 4] [SEC Form 4: Edwards Larry G. returned $74,567 worth of shares to the company (11,969 units at $6.23), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-edwards-larry-g-returned-74567-worth-of-3330124)
- 2022-08-25 00:19 UTC [SEC Form 4] [SEC Form 4 filed by Hearne Michael S](https://www.quantisnow.com/insight/sec-form-4-filed-by-hearne-michael-s-3330117)
- 2022-08-25 00:18 UTC [SEC Form 4] [SEC Form 4: Johnson Laura L. returned $3,115 worth of shares to the company (500 units at $6.23), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-johnson-laura-l-returned-3115-worth-of-3330116)
- 2022-08-25 00:17 UTC [SEC Form 4] [SEC Form 4: Johnson Craig A returned $74,760 worth of shares to the company (12,000 units at $6.23), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-johnson-craig-a-returned-74760-worth-of-3330115)
- 2022-08-25 00:17 UTC [SEC Form 4] [SEC Form 4: Hearne Michael S returned $63,459 worth of shares to the company (10,186 units at $6.23), closing all direct ownership in the company](https://www.quantisnow.com/insight/sec-form-4-hearne-michael-s-returned-63459-worth-of-3330114)
- 2022-08-24 20:02 UTC [SEC Form 4] [SEC Form 4 filed by Tang Kevin C](https://www.quantisnow.com/insight/sec-form-4-filed-by-tang-kevin-c-3328847)
- 2022-08-24 20:00 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by La Jolla Pharmaceutical Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-la-jolla-pharmaceutical-company-3328818)
- 2022-08-23 21:00 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-la-jolla-pharmaceutical-company-3323929)
- 2022-08-23 21:00 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-la-jolla-pharmaceutical-company-3323920)
- 2022-08-23 21:00 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-la-jolla-pharmaceutical-company-3323917)
- 2022-08-23 21:00 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-la-jolla-pharmaceutical-company-3323909)
- 2022-08-23 21:00 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-la-jolla-pharmaceutical-company-3323908)
- 2022-08-22 13:22 UTC [SEC Form 8-K] [La Jolla Pharmaceutical Company filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/la-jolla-pharmaceutical-company-filed-sec-form-8-k-termination-of-3315412)
- 2022-08-22 13:19 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by La Jolla Pharmaceutical Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-la-jolla-pharmaceutical-company-3315404)
- 2022-08-22 13:00 UTC [Market Chatter] [Innoviva Completes Acquisition of La Jolla Pharmaceutical At Average Price Of $6.23 Per Share](https://www.quantisnow.com/insight/innoviva-completes-acquisition-of-la-jolla-pharmaceutical-at-average-price-3315204)
- 2022-08-22 12:55 UTC [Innoviva Completes Acquisition of La Jolla Pharmaceutical](https://www.quantisnow.com/insight/innoviva-completes-acquisition-of-la-jolla-pharmaceutical-3315062)
- 2022-08-15 12:12 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by La Jolla Pharmaceutical Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-la-jolla-pharmaceutical-company-3283585)
- 2022-08-15 12:02 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-la-jolla-pharmaceutical-company-3283494)
- 2022-07-27 20:05 UTC [Dividends] [Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress](https://www.quantisnow.com/insight/innoviva-reports-second-quarter-2022-financial-results-and-highlights-recent-3194155)
- 2022-07-25 12:40 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-la-jolla-pharmaceutical-company-3178617)
- 2022-07-13 00:36 UTC [SEC Form 4] [SEC Form 4: Johnson Craig A exercised 12,000 shares at a strike of $3.93](https://www.quantisnow.com/insight/sec-form-4-johnson-craig-a-exercised-12000-shares-at-3135282)
- 2022-07-12 10:09 UTC [SEC Form SC14D9C filed by La Jolla Pharmaceutical Company](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-la-jolla-pharmaceutical-company-3130335)
- 2022-07-11 22:15 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by La Jolla Pharmaceutical Company (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-la-jolla-pharmaceutical-company-3130158)
- 2022-07-12 09:35 UTC [Market Insight] [Alibaba, Zoom Video And 76 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/alibaba-zoom-video-and-76-biggest-movers-from-yesterday-3130035)
- 2022-07-11 18:42 UTC [Market Insight] [Dow Dips Around 90 Points; La Jolla Pharmaceutical Shares Surge](https://www.quantisnow.com/insight/dow-dips-around-90-points-la-jolla-pharmaceutical-shares-surge-3128311)
- 2022-07-11 18:37 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-3128290)
- 2022-07-11 16:41 UTC [Market Insight] [Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher](https://www.quantisnow.com/insight/nasdaq-tumbles-2-pliant-therapeutics-shares-spike-higher-3127812)
- 2022-07-11 16:11 UTC [Market Insight] [Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-these-casino-stocks-are-moving-lower-heres-45-stocks-3127696)
- 2022-07-11 14:55 UTC [Market Insight] [Why U.S. Stocks Are Trading Lower; AZZ Earnings And More](https://www.quantisnow.com/insight/why-us-stocks-are-trading-lower-azz-earnings-and-more-3127342)
- 2022-07-11 13:17 UTC [Market Chatter] [La Jolla shares are trading higher after Innoviva entered into a definitive agreement to acquire the company for $5.95 per share and an incremental $0.28 per share for additional cash proceeds, or an implied enterprise value of approximately $149 million.](https://www.quantisnow.com/insight/la-jolla-shares-are-trading-higher-after-innoviva-entered-into-3126795)
- 2022-07-11 12:55 UTC [Market Insight] [The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death](https://www.quantisnow.com/insight/the-daily-biotech-pulse-europe-approves-second-round-of-booster-3126505)
- 2022-07-11 12:42 UTC [Market Chatter] [Benzinga Pro's Top 5 Stocks To Watch For Monday, Jul. 11, 2022: DWAC, JPM, RBLX, INVA, BGNE](https://www.quantisnow.com/insight/benzinga-pros-top-5-stocks-to-watch-for-monday-jul-3126432)
- 2022-07-11 12:37 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-pre-market-session-3126404)
- 2022-07-11 12:14 UTC [Market Insight] [Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal](https://www.quantisnow.com/insight/innoviva-bolsters-its-infectious-disease-hospital-portfolio-with-la-jolla-3126230)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LJPC
- Earnings history: https://www.quantisnow.com/earnings/LJPC
- Dividend history: https://www.quantisnow.com/dividends/LJPC
- Insider transactions: https://www.quantisnow.com/insiders/LJPC
- Options chain: https://www.quantisnow.com/options/LJPC
- SEC 8-K filings only: https://www.quantisnow.com/company/LJPC/8-k
- RSS and alerts for LJPC: https://www.quantisnow.com/docs/rss-feeds.md